Metacrine, Inc.
BalancedMTCR·US·🇺🇸 US
48%buys·52%sales
309 transactions$171.4MTotal buys·44 buys
$10.3MTotal sells·47 sells
4141 insiders
Last: Mar 23, 2023
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Mar 23, 23 | Klassen Preston | Disposition | - | |
| Mar 23, 23 | Klassen Preston | Grant | $396K | |
| Jan 26, 23 | Klassen Preston | Sell | $156K | |
| Jan 26, 23 | York Michael | Sell | $44K | |
| May 18, 22 | GUGGENHIME ANDREW | Grant | - | |
| May 18, 22 | Evans Ronald M | Grant | - | |
| May 18, 22 | Heyman Richard A. | Grant | - | |
| May 18, 22 | Owens Julia C. | Grant | - | |
| May 18, 22 | McHutchison John G | Grant | - | |
| May 18, 22 | JONKER JEFFREY DAVID | Grant | - |
Klassen Preston (CEO) recently executed a sell of $156K in Metacrine, Inc. shares on January 26, 2023. Insider activity shows a balanced mix of buying and selling.
Metacrine, Inc. (MTCR) has recorded 309 insider operations, including 44 open-market purchases ($171.4M), 47 sales ($10.3M) and 218 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is balanced.
Metacrine, Inc. shows moderate insider activity with 4 active months out of the last 12, typical of a company whose trading windows are concentrated around financial disclosures.
Among the most active insiders are Klassen Preston (CEO), Millican Trisha (CFO) & Chen Hubert C (C SUITE), with respectively 61, 12, 22 transactions.
Across all 309 recorded transactions, the breakdown by type is: exercise (188, 61%), sales (47, 15%), buys (44, 14%), grant (29, 9%), disposition (1, 0%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Metacrine, Inc. has recorded 309 insider operations in total, including 44 open-market purchases ($171.4M), 47 sales ($10.3M) and 218 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on March 23, 2023.
Insiders at Metacrine, Inc. show balanced activity with 48% purchases and 52% sales. Total buy volume is $171.4M versus $10.3M in sales.
InsiderLens tracks 41 insiders at Metacrine, Inc. (MTCR). Klassen Preston (CEO, 61 tx), Millican Trisha (CFO, 12 tx), Chen Hubert C (C SUITE, 22 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for MTCR is neutral, based on a 48% buy ratio across 91 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Metacrine, Inc. comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.